Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/09/057399
CTRI/2023/09/057399
Recruiting
Phase 3

A randomized controlled trial on Safety and Immunogenicity of purified verocell rabies vaccine as pre-exposure prophylaxis via Intradermal two visits (2-0-2-0-0) verses three visits (1-0-1-0-1) regimen on healthy volunteers - NI

Dr N R Ramesh Masthi0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr N R Ramesh Masthi
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr N R Ramesh Masthi

Eligibility Criteria

Inclusion Criteria

  • •Healthy subjects willing to volunteer and sign written informed consent for the study.
  • •Subjects should be available for the follow\-up period.

Exclusion Criteria

  • •?Received Anti rabies vaccine or RIG or RMAb anytime in the past.
  • •?Participation in any other clinical trial in the past three months.
  • •?Severely immunocompromised subjects, pregnant and lactating women.
  • •Subjects with known history of allergy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
evaluate the safety and immunomodulatory efficacy of Byolic CC supplementImmunomodulatory effect on healthy volunteers.
IRCT20240304061158N4Behpad Teb Iranian90
Active, not recruiting
Not Applicable
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and ChildreJapanese EncephalitisTherapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2015-005193-38-Outside-EU/EEASanofi Pasteur SA300
Completed
Phase 3
A prospective randomized controlled trial of immunoglobulin plus prednisolone for Kawasaki disease patients with high risk for coronary abnormalitiesKawasaki disease
JPRN-UMIN000009524agoya University Graduate School of Medicine, Department of Pediatrics240
Completed
Not Applicable
A randomized controlled trial of immune-enhancing enteral feeding on immunologic and nutritional status in tube-fed patientsmalnutrition
JPRN-UMIN000001326Morinaga Milk Industry Co., Ltd.126
Recruiting
Phase 3
Clinical Trial of quadrivalent Papilloguard4 vaccine (Human Papillomavirus Types 6, 11, 16, 18) manufactured by Nivad Pharmed Salamat in comparison with GardasilGenital wart prevention.Anogenital (venereal) wartsA63.0
IRCT20240120060741N1ivad Pharmed Salamat670